Home/Filings/4/0001062993-25-014701
4//SEC Filing

Herr Amy E. 4

Accession 0001062993-25-014701

CIK 0000842023other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 5:29 PM ET

Size

29.0 KB

Accession

0001062993-25-014701

Insider Transaction Report

Form 4
Period: 2025-08-15
Herr Amy E.
Director
Transactions
  • Tax Payment

    Common Stock

    2025-08-15$53.60/sh101$5,4142,154 total(indirect: By significant other)
  • Exercise/Conversion

    Common Stock

    2025-08-15+2792,255 total(indirect: By significant other)
  • Exercise/Conversion

    Restricted Stock Units

    2025-08-15119118 total(indirect: By significant other)
    Common Stock (119 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-08-15160320 total(indirect: By significant other)
    Common Stock (160 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-08-15+2,7352,735 total(indirect: By significant other)
    Exercise: $53.60Exp: 2035-08-15Common Stock (2,735 underlying)
  • Award

    Restricted Stock Units

    2025-08-15+932932 total(indirect: By significant other)
    Common Stock (932 underlying)
Holdings
  • Common Stock

    1,040
  • Stock Option (Right to Buy)

    (indirect: By significant other)
    Exercise: $66.97Exp: 2027-08-05Common Stock (4,472 underlying)
    4,472
  • Stock Option (Right to Buy)

    (indirect: By significant other)
    Exercise: $94.52Exp: 2029-08-15Common Stock (2,104 underlying)
    2,104
  • Stock Option (Right to Buy)

    (indirect: By significant other)
    Exercise: $84.61Exp: 2030-08-15Common Stock (1,084 underlying)
    1,084
  • Stock Option (Right to Buy)

    (indirect: By significant other)
    Exercise: $120.46Exp: 2028-08-06Common Stock (2,076 underlying)
    2,076
  • Restricted Stock Units

    (indirect: By significant other)
    Common Stock (115 underlying)
    115
  • Stock Option (Right to Buy)

    Exercise: $72.05Exp: 2035-02-03Common Stock (2,415 underlying)
    2,415
  • Stock Option (Right to Buy)

    (indirect: By significant other)
    Exercise: $47.60Exp: 2026-08-07Common Stock (6,636 underlying)
    6,636
  • Stock Option (Right to Buy)

    (indirect: By significant other)
    Exercise: $72.05Exp: 2035-02-03Common Stock (344 underlying)
    344
  • Stock Option (Right to Buy)

    (indirect: By significant other)
    Exercise: $74.91Exp: 2034-08-15Common Stock (1,468 underlying)
    1,468
Footnotes (13)
  • [F1]This option vests on the earlier of the one-year anniversary of the grant date (2/3/2025) or the date of Bio-Techne's 2025 annual meeting of shareholders.
  • [F10]160 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.
  • [F11]38 restricted stock units vest on each of 2/3/2026 and 2/3/2027, and 39 restricted stock units vest on 2/3/2028.
  • [F12]311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028.
  • [F13]Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028.
  • [F2]Fully vested.
  • [F3]Options to purchase 520 shares vest on each of 8/6/2022, 8/6/2023 and 8/6/2025; and options to purchase 516 shares vest on 8/6/2024.
  • [F4]Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026.
  • [F5]Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
  • [F6]Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
  • [F7]Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.
  • [F8]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  • [F9]119 restricted stock units vest on 8/15/2025 and 118 restricted stock units vest on 8/15/2026.

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeother

Related Parties

1
  • filerCIK 0002055523

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 5:29 PM ET
Size
29.0 KB